93 5514 93 5514 (Carbamazepine extended-release 300 mg)

Pill imprint 93 5514 93 5514 has been identified as Carbamazepine extended-release 300 mg.

Carbamazepine is used in the treatment of trigeminal neuralgia; bipolar disorder; epilepsy; schizoaffective disorder; cluster-tic syndrome (and more), and belongs to the drug class dibenzazepine anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Carbamazepine 300 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for 93 5514 93 5514

Carbamazepine extended-release 300 mg 93 5514 93 5514
Carbamazepine extended-release
Imprint:
93 5514
93 5514
Strength:
300 mg
Color:
Green / Black
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Dibenzazepine anticonvulsants
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Teva Pharmaceuticals USA Inc.
National Drug Code (NDC):
00093-5514
Inactive Ingredients:
carnauba wax
D&C Yellow No. 10
FD&C Green No. 3
gelatin
ferrosoferric oxide
lactose monohydrate
polyethylene glycol 1450
propylene glycol
shellac
sodium lauryl sulfate
sorbitan monolaurate
titanium dioxide
povidone
sodium hydroxide

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web4)